Treatment of severe neonatal infections with cefotaxime. Efficacy and pharmacokinetics
- 1 March 1982
- journal article
- research article
- Published by Elsevier in The Journal of Pediatrics
- Vol. 100 (3), 483-489
- https://doi.org/10.1016/s0022-3476(82)80466-6
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- Sepsis NeonatorumNew England Journal of Medicine, 1981
- Human metabolism of cefotaximeJournal of Antimicrobial Chemotherapy, 1980
- Cefotaxime in the treatment of severe paediatric infectionsJournal of Antimicrobial Chemotherapy, 1980
- Metabolism of cefotaxime in animals and manJournal of Antimicrobial Chemotherapy, 1980
- HR 756, a Highly Active Cephalosporin: Comparison with Cefazolin and CarbenicillinAntimicrobial Agents and Chemotherapy, 1978
- Cefotaxime (HR 756) a new cephalosporin with exceptional broad-spectrum activity in vitroJournal of Antimicrobial Chemotherapy, 1978
- Activity of HR 756 against Haemophilus influenzae, Barteroides fragilis and Gram-negative rodsJournal of Antimicrobial Chemotherapy, 1978
- Linear pharmacokinetic equations allowing direct calculation of many needed pharmacokinetic parameters from the coefficients and exponents of polyexponential equations which have been fitted to the dataJournal of Pharmacokinetics and Biopharmaceutics, 1976
- CSTRIP, a Fortran IV Computer Program for Obtaining Initial Polyexponential Parameter EstimatesJournal of Pharmaceutical Sciences, 1976
- Statistical estimations in pharmacokineticsJournal of Pharmacokinetics and Biopharmaceutics, 1974